Search Results - "Gaillard, Pieter J"
-
1
Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)
Published in PloS one (08-01-2014)“…Brain cancer is a devastating disease affecting many people worldwide. Effective treatment with chemotherapeutics is limited due to the presence of the…”
Get full text
Journal Article -
2
Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation
Published in Journal of controlled release (28-12-2012)“…Neuroinflammation contributes to a wide range of disorders of the central nervous system (CNS). Of the available anti-inflammatory drugs, only glucocorticoids…”
Get full text
Journal Article -
3
Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood-brain barrier in rats
Published in Journal of drug targeting (01-06-2014)“…Abstract Partly due to poor blood-brain barrier drug penetration the treatment options for many brain diseases are limited. To safely enhance drug delivery to…”
Get full text
Journal Article -
4
A novel co-culture model of the blood-retinal barrier based on primary retinal endothelial cells, pericytes and astrocytes
Published in Experimental eye research (01-03-2012)“…Loss of blood-retinal barrier (BRB) properties is an important feature in the pathology of diabetic macular edema (DME), but cellular mechanisms underlying BRB…”
Get full text
Journal Article -
5
Targeted blood-to-brain drug delivery --10 key development criteria
Published in Current pharmaceutical biotechnology (01-09-2012)“…Drug delivery to the brain remains challenging due to the presence of the blood-brain barrier. In this review, 10 key development criteria are presented that…”
Get more information
Journal Article -
6
Imaged-guided focused ultrasound in combination with various formulations of doxorubicin for the treatment of diffuse intrinsic pontine glioma
Published in Translational medicine communications (18-04-2022)“…Abstract Background Diffuse intrinsic pontine glioma (DIPG) is a notoriously difficult tumor to treat, with an overall survival of DIPG patients being only…”
Get full text
Journal Article -
7
Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017
Published in Fluids and barriers of the CNS (07-11-2017)“…This is a report on the CNS barrier congress held in London, UK, March 22-23rd 2017 and sponsored by Kisaco Research Ltd. The two 1-day sessions were chaired…”
Get full text
Journal Article -
8
Treatment with penicillin G and hydrocortisone reduces ALS-associated symptoms: a case series of three patients
Published in F1000 research (2017)“…Three male Caucasian patients with ALS were admitted to the hospital due to progressive dysphagia and dysarthria. During two 21-day courses of penicillin G and…”
Get full text
Journal Article -
9
Correction to: Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017
Published in Fluids and barriers of the CNS (12-01-2018)“…After publication of the article [1], it has been brought to our attention that there are some errors in the formatting of names in the final version of the…”
Get full text
Journal Article -
10
Targeted brain delivery of methotrexate by glutathione PEGylated liposomes: How can the formulation make a difference?
Published in European journal of pharmaceutics and biopharmaceutics (01-06-2019)“…[Display omitted] The purpose of this study was to quantitatively investigate how conjugation of GSH to different liposomal formulations influence the brain…”
Get full text
Journal Article -
11
Enhanced doxorubicin delivery to the brain administered through glutathione PEGylated liposomal doxorubicin (2B3-101) as compared with generic Caelyx,(®)/Doxil(®)--a cerebral open flow microperfusion pilot study
Published in Journal of pharmaceutical sciences (01-07-2014)“…The neuroprotective blood-brain barrier (BBB) keeps many drug candidates below therapeutic levels in the central nervous system. Glutathione PEGylated…”
Get more information
Journal Article -
12
In vivo Functional Evaluation of Increased Brain Delivery of the Opioid Peptide DAMGO by Glutathione-PEGylated Liposomes
Published in Pharmaceutical research (01-01-2016)“…Purpose The purpose of this study was to evaluate formulation factors causing improvement in brain delivery of a small peptide after encapsulation into a…”
Get full text
Journal Article -
13
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
Published in Pharmaceuticals (Basel, Switzerland) (16-12-2011)“…RNA interference (RNAi) allows the specific knockdown of tumor relevant genes. To induce RNAi, the delivery of small interfering RNAs (siRNAs) is of crucial…”
Get full text
Journal Article -
14
The Impact of Liposomal Formulations on the Release and Brain Delivery of Methotrexate: An In Vivo Microdialysis Study
Published in Journal of pharmaceutical sciences (01-09-2017)“…The impact of liposomal formulations on the in vivo release and brain delivery of methotrexate (MTX) was quantitatively assessed in rats. Two PEGylated…”
Get more information
Journal Article -
15
Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease
Published in Journal of controlled release (10-04-2015)“…Treatment of neurodegenerative disorders such as Alzheimer's disease is hampered by the blood-brain barrier (BBB). This tight cerebral vascular endothelium…”
Get full text
Journal Article -
16
Enhanced Brain Delivery of the Opioid Peptide DAMGO in Glutathione PEGylated Liposomes: A Microdialysis Study
Published in Molecular pharmaceutics (06-05-2013)“…Glutathione PEGylated (GSH-PEG) liposomes were evaluated for their ability to enhance and prolong blood-to-brain drug delivery of the opioid peptide DAMGO…”
Get full text
Journal Article -
17
In Vivo Quantitative Understanding of PEGylated Liposome’s Influence on Brain Delivery of Diphenhydramine
Published in Molecular pharmaceutics (03-12-2018)“…Despite the promising features of liposomes as brain drug delivery vehicles, it remains uncertain how they influence the brain uptake in vivo. In order to gain…”
Get full text
Journal Article -
18
BBB crossing assessment and BBB crossing technologies in CNS Drug Discovery
Published in Drug discovery today. Technologies (01-06-2016)Get full text
Journal Article -
19
Glutathione PEGylated liposomal methylprednisolone (2B3-201) attenuates CNS inflammation and degeneration in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis
Published in Journal of neuroimmunology (15-09-2014)“…Abstract Methylprednisolone (MP) pulses are the mainstay for relapse therapy in multiple sclerosis (MS). To improve the efficacy of treatment and reduce the…”
Get full text
Journal Article -
20
Strategies to improve drug delivery across the blood-brain barrier
Published in Clinical pharmacokinetics (01-01-2007)“…The blood-brain barrier (BBB), together with the blood-cerebrospinal-fluid barrier, protects and regulates the homeostasis of the brain. However, these…”
Get full text
Journal Article